FDA Reclassifies Some Electroconvulsive Therapy Devices to Lower Risk Category

The FDA published a final order requiring manufactures to file for a PMA for most uses of ECT devices. This order also reclassified ECT devices used in the treatment of catatonia or severe major depressive episodes.